
|Videos|February 24, 2016
Robert Andtbacka on Managing Side Effects From T-VEC
Author(s)Robert Andtbacka, MD
Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Advertisement
Robert Andtbacka, MD, associate professor, Division of Surgical Oncology, Department of Surgery, University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Rigors and chills are quite common, but can be managed fairly easily. If a patient experiences these side effects, Andtbacka says, a physician should premeditate him or her with Tylenol and antihistamines in future treatments. After 5-7 injections, the side effects usually go away completely.
Overall, T-VEC is very well tolerated and most patients can go to work and continue with other everyday activities.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients
2
FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications
3
Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities
4
Personalizing Frontline ADC Selection in Metastatic Triple-Negative Breast Cancer
5



















































